Literature DB >> 17574589

Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts.

Ho-Soon Choi1, Christopher E Savard, Jae-Woon Choi, Rahul Kuver, Sum P Lee.   

Abstract

BACKGROUND: The cellular and molecular mechanisms of fibrogenesis in the extrahepatic biliary epithelium are not known. Transforming growth factor-beta1 (TGF-beta1) is a cytokine implicated in signaling pathways that mediate collagen formation. An observation that paclitaxel (PT), applied topically into the rat common bile duct, inhibited stricture formation led us to hypothesize that PT's effects might be due to interruption of TGF-beta1 signaling between biliary epithelial cells and subepithelial myofibroblasts.
MATERIALS AND METHODS: We tested this hypothesis using an in vitro cell-culture model in which murine gallbladder epithelial cells (GBEC) are cultured separately or cocultured with human gallbladder myofibroblasts (GBMF).
RESULTS: Exposure to Escherichia coli lipopolysaccharide (LPS) enhanced TGF-beta1 mRNA expression and stimulated TGF-beta1 protein secretion into both apical and basolateral compartments in GBEC. This effect was more prominent with basolateral secretion and was also more pronounced in the coculture system. In GBMF, collagen I mRNA expression and protein secretion were stimulated by treatment with LPS or TGF-beta1. GBMF also expressed TGF-beta1 mRNA, whose levels were enhanced by exposure to either LPS or exogenous TGF-beta1. PT inhibited LPS-induced TGF-beta1 mRNA expression and protein secretion in GBEC in both culture systems. Tumor necrosis factor-alpha mRNA expression and protein secretion were not affected by PT in GBEC, demonstrating that the effects were specific for TGF-beta1. PT also inhibited LPS- and TGF-beta1-induced collagen I mRNA expression and protein secretion in GBMF.
CONCLUSIONS: These findings support a model in which GBEC communicate with subepithelial GBMF via TGF-beta1, leading to collagen deposition and fibrosis, and in which GBMF possess autocrine mechanisms involving TGF-beta1 that could regulate collagen production. PT inhibits these fibrogenic pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574589      PMCID: PMC3571727          DOI: 10.1016/j.jss.2006.12.558

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  38 in total

1.  Biliary strictures as a cause of primary intrahepatic bile duct stones.

Authors:  Y Matsumoto; H Fujii; M Yoshioka; T Sekikawa; T Wada; M Yamamoto; H Eguchi; K Sugahara
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

2.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Promotion of microtubule assembly in vitro by taxol.

Authors:  P B Schiff; J Fant; S B Horwitz
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

4.  Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.

Authors:  S Mundlos; D Chan; Y M Weng; D O Sillence; W G Cole; J F Bateman
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

5.  Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel.

Authors:  Seon-Mee Park; Jae-Woon Choi; Seung-Taik Kim; Myung-Chan Cho; Ryo Hyen Sung; Lee-Chan Jang; Jin-Woo Park; Sum Ping Lee; Yong-Hyun Park
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

6.  Pathologic features of hepatolithiasis in Japan.

Authors:  Y Nakanuma; K Yamaguchi; G Ohta; T Terada
Journal:  Hum Pathol       Date:  1988-10       Impact factor: 3.466

7.  Taxol stabilizes microtubules in mouse fibroblast cells.

Authors:  P B Schiff; S B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.

Authors:  M J Czaja; F R Weiner; K C Flanders; M A Giambrone; R Wind; L Biempica; M A Zern
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

9.  Expression of cytokine and chemokine mRNA and secretion of tumor necrosis factor-alpha by gallbladder epithelial cells: response to bacterial lipopolysaccharides.

Authors:  Christopher E Savard; Thane A Blinman; Ho-Soon Choi; Sung-Koo Lee; Stephen J Pandol; Sum P Lee
Journal:  BMC Gastroenterol       Date:  2002-10-11       Impact factor: 3.067

10.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Authors:  A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  14 in total

1.  A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer.

Authors:  Hidehiro Tajima; Isamu Makino; Ryosuke Gabata; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Hiroyuki Shimbashi; Shinich Nakanuma; Hiroto Saitoh; Mari Shimada; Takahisa Yamaguchi; Koichi Okamoto; Hideki Moriyama; Jun Kinoshita; Keishi Nakamura; Tomoharu Miyashita; Itasu Ninomiya; Sachio Fushida; Hiroko Ikeda; Tetsuo Ohta
Journal:  Mol Clin Oncol       Date:  2020-12-14

2.  Paclitaxel-Releasing Thin Biodegradable Film for Prevention of Bleb Avascularity Without Compromising Filtration in Rabbits.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Mayumi Sakurai; Yukako Fukuhira; Hiroaki Kaneko; Masatsugu Shimomura; Kazuhisa Sugiyama
Journal:  Transl Vis Sci Technol       Date:  2015-06-11       Impact factor: 3.283

3.  Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.

Authors:  Hidehiro Tajima; Isamu Makino; Yoshinao Ohbatake; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hiroyuki Takamura; Tetsuo Ohta
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

4.  Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hiroyuki Shinbashi; Atsushi Hirose; Mitsuyoshi Okazaki; Takahisa Yamaguchi; Yoshinao Ohbatake; Koichi Okamoto; Shinichi Nakanuma; Seisho Sakai; Jun Kinoshita; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Tomoharu Miyashita; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Hiroyuki Nakamura
Journal:  Mol Clin Oncol       Date:  2017-03-30

5.  Cytokine single nucleotide polymorphisms in patients' with gallstone: dose TGF-β gene variants affect gallstone formation?

Authors:  Padideh Ebadi; Saeed Daneshmandi; Abbas Ghasemi; Mohammad Hossein Karimi
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

6.  Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hiroyuki Shinbashi; Atsushi Hirose; Tomoya Tsukada; Koichi Okamoto; Shinichi Nakanuma; Seisho Sakai; Hiroyuki Furukawa; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Hisatsugu Mouri; Koushiro Ohtsubo
Journal:  Oncol Lett       Date:  2012-09-12       Impact factor: 2.967

7.  Epithelial-mesenchymal transitions of bile duct epithelial cells in primary hepatolithiasis.

Authors:  Lijin Zhao; Rigao Yang; Long Cheng; Maijian Wang; Yan Jiang; Shuguang Wang
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

8.  Glycochenodeoxycholic Acid Does Not Increase Transforming Growth Factor-Beta Expression in Bile Duct Epithelial Cells or Collagen Synthesis in Myofibroblasts.

Authors:  Anna Wang; Dorothy Yu; Yuewen Gong; Jessie Garber; Gerald Y Minuk
Journal:  J Clin Exp Hepatol       Date:  2017-05-13

9.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

10.  Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

Authors:  Tomoya Tsukada; Sachio Fushida; Shinichi Harada; Shiroh Terai; Yasumichi Yagi; Jun Kinoshita; Katsunobu Oyama; Hidehiro Tajima; Itasu Ninomiya; Takashi Fujimura; Tetsuo Ohta
Journal:  Int J Oncol       Date:  2013-01-29       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.